
Lenalid 5mg Capsule
Salt Composition: Lenalidomide
Expiry Date: 01/2028
Inclusive of all taxes
30 Capsule
About The Product
Blood Cell Cancers, Leukemia
Lenalid Capsule is an immunomodulatory anticancer medicine that modulates the immune system. This tablet is prescribed to treat multiple myeloma, mantle cell lymphoma, myelodysplastic syndrome, and follicular lymphoma. It belongs to the class of immunotherapy drugs that provide strength to our body's immune system to fight against life-threatening diseases. It is strictly prescription-based medicine.
Side Effects
- Mydekla 60mg tablet may cause some side effects that vary from one patient to another.
- Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
- Common side effects include: Tiredness Constipation Anaemia Fever Back pain Nausea Breathlessness Tremor Rash Cough Headache Dehydration Skin problems Serious side effects: Severe allergic reactions High risk of secondary cancer Liver toxicity Blurred vision Difficulty speaking Faster heartbeat Chest pain or leg pain Contact your doctor immediately if you ever experienced any serious or persistent side effects.
How To Use
- Lenalid 5mg Capsule is a prescription-based anticancer drug that should be administered orally.
- It is advised to take this capsule after consulting your healthcare expert.
- This capsule should be taken with or without food, but at the fix time every day to get effective results.
- Don't miss a dose or overdose on the medicine.
How It Works
Lenalid 5mg Capsule comes under the category of medicines termed as Immunomodulatory agents. The active ingredient of this anticancer drug is Lenalidomide.
This Capsule strengthens the immune system to attack cancer cells. This medicine stops the formation of new blood vessels from growing in cancer cells.
It also reduces the production of chemical messengers that help cancer cells multiply uncontrollably and kill the abnormal cancer cells in the bone marrow. Also it helps in the production of normal blood cells.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Lenalid 5mg Capsule.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
It is advised to go for regular blood tests before and during the treatment as Lenalid 5mg Capsule may lead to a reduction in WBC (white blood cells) and platelets. These components are required to fight infections in the body.
Avoid physical work that may result in bruising or injury. Stay away from people having colds or infections.
Lenalid 5mg Capsule makes your skin sensitive to sunlight as one of the side effects. Always apply sunscreen when going out.
Dehydration is a symptom observed after taking Lenalid 5mg Capsule. Drink enough water to maintain the hydration level while taking medication.
Inform your dentist before receiving any dental care that you're undergoing treatment with Lenalid 5mg Capsule.
FAQs
Lenalid 5mg Capsule belongs to the category of medicines known as immunomodulatory.
Reference
1. Fink, E.
C., & Ebert, B. L.
(2015). The novel mechanism of lenalidomide activity.
Blood, The Journal of the American Society of Hematology, 126(21), 2366-2369. 2.
Lee, S., Hwang, J. G., Park, S.
Y., Lim, H. J., Lee, S.
W., Seo, M. H., ... & Hong, J.
H. (2018).
Single-dose comparative pharmacokinetics of two formulations of lenalidomide 25 mg in healthy subjects: a randomized crossover study. Advances in Therapy, 35(2), 210-217.
3. Lindfelt, T., & Ignoffo, R.
(2012). Oral Chemotherapy (Part II): What Every Pharmacist Should Know.
California Journal of Health-System Pharmacy, 24(5). 4.
Rao, K. V.
(2007). Lenalidomide in the treatment of multiple myeloma.
American Journal of Health-System Pharmacy, 64(17), 1799-1807. 5.
Kotla, V., Goel, S., Nischal, S., Heuck, C., Vivek, K., Das, B., & Verma, A. (2009).
Mechanism of action of lenalidomide in hematological malignancies. Journal of hematology & oncology, 2(1), 36.
6. Armoiry, X., Aulagner, G., & Facon, T.
(2008). Lenalidomide in the treatment of multiple myeloma: a review.
Journal of clinical pharmacy and therapeutics, 33(3), 219-226.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
